14 ML bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection
RxNorm concept 2560312, clinical drug (scd). Prescribable name: BUPivacaine 400 MG / meloxicam 12 MG in 14 ML Extended Release Solution.
- RxCUI
- 2560312
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2560312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
14 ML BUPivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection; BUPivacaine 400 MG / meloxicam 12 MG per 14 ML Extended Release Solution; bupivacaine 400 MG / meloxicam 12 MG per 14 ML Extended Release Solution
Related concepts
- meloxicam 0.88 MG/ML (SCDC, consists of)
- bupivacaine 29.3 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 14 ML bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection [Zynrelef] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2560312 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2560312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2560312. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.